Closed
3.51 -0.28
24h
Min
3.36
Max
3.53
Income | 7.2M -13M |
---|---|
Sales | 235K 1.6M |
EPS | -0.1 |
Profit margin | -796.188 |
Employees | 44 |
EBITDA | 7.2M -12M |
Recommendations | Buy |
---|---|
12 Months Forecast | +42.45% upside |
Next Earnings | 1 May 2025 |
---|
Market Cap | 27M 669M |
---|---|
Previous open | 3.79 |
Previous close | 3.51 |
By Trading Central
Confidence
Very Strong Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 5 USD 42.45%
High 5 USD
Low 5 USD
Based on 2 Wall Street analysts offering 12 month price targets forArbutus Biopharma Corp - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$